Abstract
Clinical and/or biological improvement has been observed in 7 out of 17 patients with hyperprolactinemic amenorrhea followed for 6–15 months after the successful outcome of bromocriptine (Parlodel®, Sandoz)-induced pregnancy. The ovulatory cycle was resumed in 2 out of these 7 patients (with subsequent spontaneous conception in 1); in 3 others the medroxyprogesterone acetate test became positive. In all cases, post-partum prolactin values were considerably reduced. The possible causes of this improvement are discussed, examining the present data and those in the literature. Regressive lesions, due for example to vascularization defects or hemorrhage occurring in the prolactin-secreting tissue, as a result of the hyperplastic stimulus of estrogens during pregnancy, are suggested as a possible explanation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rjosk H.K., Fahlbusch R., Huber K., von Werder K. Growth of prolactin producing pituitary adenomas during pregnancy. In: Fahlbusch R., Von Werder K. (Eds.), Treatment of pituitary adenomas. G. Thieme Publishers, Stuttgart, 1978, p. 395.
Rjosk H.K., Huber H. Pregnancies in patients with prolactinomas. Acta Endocrinol. (Kbh.) (Suppl.) 87: 2, 1978.
Mornex R., Orgiazzi J., Hugues B., Gagnaire J.C., Claustrat B. Normal pregnancies after treatment of hyperprolactinemia with bromoergocriptine, despite suspected pituitary tumors. J. Clin. Endocrinol. Metab. 47: 290, 1978.
Bergh T., Nillius S.J., Wide L. Bromocriptine treatment of 42 hyperprolactinemic women with secondary amenorrhea. Acta Endocrinol. (Kbh.) 88: 435, 1978.
Bergh T., Nillius S.J., Wide L. Hyperprolactinemic amenorrhea. Results of treatment with bromocriptine. Acta Endocrinol. (Kbh.) (Suppl.) 88: 147, 1978.
Nencioni T, Miragoli A, Antolini C., Polvani F. Induzione della gravidanza con bromocriptina nei microprolattinomi. Triangolo (Suppl.) 16: 109, 1978.
Corenblum B. Successful outcome of ergocriptine-induced pregnancies in twenty-one women with prolactin-secreting pituitary adenomas. Fertil. Steril. 32: 183, 1979.
Cowden E.A., Thomson J.A. Resolution of hyperprolactinaemia after bromocriptine-induced pregnancy. Lancet 1: 613, 1979.
Noble A.D. Resolution of hyperprolactinaemia after bromocriptine-induced pregnancy. Lancet 1: 1079, 1979.
Vezina J.L., Sutton T.J. Prolactin secreting pituitary microadenomas. Am. J. Roentgenol 120: 46, 1974.
Reuter A.M., Kennes F., Gevaert Y., Franchimont P. Dosage radioimmonologique homologue de la prolactine humaine. Pathol. Biol. (Paris) 23: 761, 1975.
Me Kenna T.J., Glick A.D., Cobb C., Jacobs L.S. Galactorrhea and hypogonadism associated with a radiologically inapparent prolactin secreting pituitary tumor. Acta Endocrinol. (Kbh.) 87: 225, 1978.
Burry K.A., Schiller H.S., Mills R., Harris B., Heinrichs L. Acute visual loss during pregnancy after bromocriptine-induced ovulation. The elusive tumor. Obstet. Gynecol. 52: 19, 1978.
Quadri S.K., Lu K.H., Meites J. Ergot-induced inhibition of pituitary tumor growth in rats. Science 176: 417, 1972.
Mac Leod R.M., Lehmeyer J.E. Suppression of pituitary tumour growth and function by ergot alkaloids. Cancer Res. 33: 849, 1973.
Lloyd H.M., Meares J.D., Jacobi J. Effects of oestrogens and bromocriptine on in vivo secretion and mitosis in prolactin cells. Nature 255: 497, 1975.
Nillius S.J., Bergh T., Lundberg P.O. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine. Fertil. Steril. 30: 710, 1978.
Aronoff S.L., Daughaday W.H., Laws E.R. Jr. Bromocriptine treatment of prolactinomas. N.Engl. J. Med. 300: 1391, 1979.
Me Gregor A.M., Scanlon M.F., Hall K., Cook D.B., Hall R. Reduction in size of pituitary tumor by bromocriptine therapy. N. Engl. J. Med. 300: 291, 1979.
Bergh T., Nillius S.J., Lundberg P.O., Wide L. Bromocriptine treatment of prolactinomas. N. Engl. J. Med. 300: 1391, 1979.
Von Werder K., Eversmann T., Fahlbusch R., Rjosk H.K. Bromocriptine treatment of prolactinomas N. Engl. J. Med. 300: 1391, 1979.
Landolt A.M. Biology of pituitary adenomas. Proceedings of International Symposium on Pituitary Microadenomas, Milan, October 12–14, 1978, p. 18 (Abstract).
Racadot J., Peillon F., Oliver L, Vila-Porcile E., Recadot O., Moussy D. Prolactin secreting pituitary adenomas: morphology and clinical data in 157 male and female patients. Acta Endocrinol. (Kbh.) (Suppl.) 84: 55, 1977.
Corbey R.S., Cruysberg J.R.M., Rolland R. Visual abnormalities in a pregnancy following bromo-criptin medication. Obstet. Gynecol. 50: 69, 1977.
Gemzell G., Wang C.F. Outcome of pregnancy in women with pituitary adenoma. Fertil. Steril 31: 363, 1979.
Lamberts S.W.J., Seldeurath H.J., Kwa H.G., Birkenhäger J.C. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine. J. Clin. Endocrinol. Metab. 44: 180, 1977.
Bergh T., Nillius S.J., Wide L. Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumours. Br. J. Med. 1: 875, 1978.
Buvat J., Gauthier A., Gasnault J.P., Pagniez I., Monnier J.C., Linquette M. Hypoplasie ovarienne primitive et micro-adénome à prolactine: apoplexie hypophysaire lors d’une grossesse permise par la bromocriptine. Gynécologie 29: 145, 1978.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Campagnoli, C., Belforte, L., Massara, F. et al. Partial remission of hyperprolactinemic amenorrhea after bromocriptine-induced pregnancy. J Endocrinol Invest 4, 85–91 (1981). https://doi.org/10.1007/BF03349421
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349421